Results 21 to 30 of about 886 (110)
Avaliação de causalidade em farmacovigilância: princípios e fundamentos da inferência causal
RevSALUS, 2022 A causalidade (ou inferência causal) é um tópico de intenso debate desde há muito tempo entre filósofos, epidemiologistas, estatísticos e outros cientistas clínicos.
Renato Ivo Ferreira da Silva
doaj +1 more source
Pain Research and Management, Volume 2020, Issue 1, 2020., 2020 The objective of this cohort study was to determine the association between the use of tramadol in emergency departments and the later consumption of opioids at the outpatient level in a group of patients from Colombia. Based on a medication dispensation database, patients over 18 years of age treated in different clinics in Colombia who for the first ...
Jorge Enrique Machado-Alba +5 more
wiley +1 more source
Evaluation of Treatment Patterns and Direct Costs Associated with the Management of Neuropathic Pain
Pain Research and Management, Volume 2020, Issue 1, 2020., 2020 Background. Neuropathic pain has a prevalence of 2–17% in the general population. Diagnosis and treatment of neuropathic pain are not fully described in different populations. The aim was to determine the treatment patterns and direct costs of care associated with the management of neuropathic pain from the onset of the first symptom to up to two years
Manuel E Machado-Duque +4 more
wiley +1 more source
Arquivos de Neuro-Psiquiatria, 2006 OBJECTIVE: To investigate the occurrence of adverse effects of antiepileptic drugs (AED) in chronic epileptic patients in mono or polytherapy. METHOD: We evaluated consecutive patients that met the following inclusion criteria: age of 18 years or older ...
Paulo Afonso Mei +3 more
doaj +1 more source
Clinical and Biomedical Research, 2020 Objetivo: Apresentar os resultados das avaliações das notificações de reações adversas a medicamentos ocorridas em pacientes internados em unidades pediátricas do Hospital de Clínicas de Porto Alegre, no período de abril de 2002 a outubro de 2003 ...
Roberta Pereira Veiga +2 more
doaj +1 more source
A evolução da farmacovigilância no Brasil - DOI: 10.4025/actascihealthsci.v27i2.1377
Acta Scientiarum. Health Sciences, 2008 Este trabalho faz um breve relato sobre os aspectos conceituais e os marcos históricos que envolvem a Farmacovigilância. São abordados os caminhos que levaram ao desenvolvimento da Farmacovigilância no mundo e no Brasil, finalizando com as perspectivas ...
Késia Gemima Palma Rigo +1 more
doaj +1 more source
Experiência de farmacovigilância no Hospital Universitário Regional de Maringá, Estado do Paraná
Acta Scientiarum. Health Sciences, 2008 Este trabalho relata a experiência da investigação dos casos suspeitos de reações adversas registrados no Hospital Universitário Regional de Maringá, Estado do Paraná.
Paula Nishiyama +3 more
doaj +1 more source
ABCS Health Sciences, 2018 Introdução: Reações adversas e os incidentes associados com medicamentos ocasionam a morte e ameaçam a segurança do paciente. No Brasil, persiste-se uma escassez de dados epidemiológicos e uma abordagem ainda insuficiente.
Alan Maicon de Oliveira +4 more
doaj +1 more source
Treatment Patterns of Patients With Pulmonary Hypertension: A Descriptive Study in Colombia
The Clinical Respiratory Journal, Volume 19, Issue 2, February 2025.This study describes the treatment patterns among ambulatory patients with pulmonary hypertension (PH) in Colombia, from a population‐based drug‐dispensing database between 2022 and 2023. It found that patients with PH from Colombia were treated predominantly with monotherapy of calcium channel blockers and phosphodiesterase 5 inhibitors, with an ...
Manuel Machado‐Duque +8 more
wiley +1 more source
Prescription patterns of ambrisentan in some cities of Colombia
The Clinical Respiratory Journal, Volume 18, Issue 3, March 2024.This group of Colombian patients with diagnosis of pulmonary hypertension and were undergoing treatment with ambrisentan is mainly women, approximately 51 years of age. They are often receiving combined therapy with other medications, especially phosphodiesterase 5 inhibitors, at the dosages recommended by clinical practice guidelines. In patients with
Luis Fernando Valladales‐Restrepo +4 more
wiley +1 more source